Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients

被引:105
作者
Fauchier, T. [1 ]
Hasseine, L. [1 ]
Gari-Toussaint, M. [1 ]
Casanova, V. [2 ]
Marty, P. M. [1 ,3 ,4 ]
Pomares, C. [1 ,3 ,4 ]
机构
[1] CHU Archet 2, Lab Parasitol Mycol, Nice, France
[2] CHU Nice, Hop Cimiez, Dept Med Informat, F-06202 Nice, France
[3] Fac Med Nice, INSERM, U1065, C3M,Toxines Microbiennes Relat Hote Pathogenes, U210, F-06034 Nice, France
[4] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France
关键词
REAL-TIME PCR; INFANT-DEATH-SYNDROME; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; CARINII-PNEUMONIA; INFECTED PATIENTS; IMMUNOSUPPRESSIVE THERAPY; CLINICAL-SIGNIFICANCE; GENERAL-POPULATION; CONVENTIONAL PCR;
D O I
10.1128/JCM.03174-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumocystis jirovecii pneumonia (PCP) is an acute and life-threatening lung disease caused by the fungus Pneumocystis jirovecii. The presentation of PCP in HIV-positive patients is well-known and consists of a triad of dyspnea, fever, and cough, whereas the presentation of PCP in HIV-negative patients is atypical and consists of a sudden outbreak, O-2 desaturation, and a rapid lethal outcome without therapy. Despite the availability of direct and indirect identification methods, the diagnosis of PCP remains difficult. The cycle threshold (C-T) values obtained by quantitative PCR (qPCR) allow estimation of the fungal burden. The more elevated that the fungal burden is, the higher the probability that the diagnosis is pneumonia. The purposes of the present study were to evaluate the C-T values to differentiate colonization and pneumonia in a population of immunocompromised patients overall and patients stratified on the basis of their HIV infection status. Testing of bronchoalveolar lavage (BAL) fluid samples from the whole population of qPCR-positive patients showed a mean C-T value for patients with PCP of 28 (95% confidence interval [CI], 26 to 30) and a mean C-T value for colonized patients of 35 (95% CI, 34 to 36) (P < 10(-3)). For the subgroup of HIV-positive patients, we demonstrated that a C-T value below 27 excluded colonization and a C-T value above 30 excluded PCP with a specificity of 100% and a sensitivity of 80%, respectively. In the subgroup of HIV-negative patients, we demonstrated that a C-T value below 31 excluded colonization and a C-T value above 35 excluded PCP with a specificity of 80% and a sensitivity of 80%, respectively. Thus, qPCR of BAL fluid samples is an important tool for the differentiation of colonization and pneumonia in P. jirovecii-infected immunocompromised patients and patients stratified on the basis of HIV infection status with different C-T values.
引用
收藏
页码:1487 / 1495
页数:9
相关论文
共 71 条
  • [1] Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
    Alanio, A.
    Desoubeaux, G.
    Sarfati, C.
    Hamane, S.
    Bergeron, A.
    Azoulay, E.
    Molina, J. M.
    Derouin, F.
    Menotti, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (10) : 1531 - 1537
  • [2] Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens
    Alvarez-Martinez, Miriam J.
    Miro, Jose M.
    Eugenia Valls, Maria
    Moreno, Asuncion
    Rivas, Paula V.
    Sole, Manel
    Benito, Natividad
    Domingo, Pere
    Munoz, Carmen
    Rivera, Esteban
    Zar, Heather J.
    Wissmann, Gustavo
    Diehl, Ada R. S.
    Prolla, Joao C.
    Jimenez de Anta, Maria Teresa
    Gatell, Jose M.
    Wilson, Paul E.
    Meshnick, Steven R.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 56 (02) : 153 - 160
  • [3] A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid
    Arcenas, RC
    Uhl, JR
    Buckwalter, SP
    Limper, AH
    Crino, D
    Roberts, GD
    Wengenack, NL
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (03) : 169 - 175
  • [4] PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITHOUT AIDS, 1980 THROUGH 1993 - AN ANALYSIS OF 78 CASES
    AREND, SM
    KROON, FP
    VANTWOUT, JW
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (22) : 2436 - 2441
  • [5] Pneumocystis Workshop: 10th Anniversary Summary
    Beck, James M.
    Cushion, Melanie T.
    [J]. EUKARYOTIC CELL, 2009, 8 (04) : 446 - 460
  • [6] Clinical Significance of Quantifying Pneumocystis jirovecii DNA by Using Real-Time PCR in Bronchoalveolar Lavage Fluid from Immunocompromised Patients
    Botterel, Francoise
    Cabaret, Odile
    Foulet, Francoise
    Cordonnier, Catherine
    Costa, Jean-Marc
    Bretagne, Stephane
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (02) : 227 - 231
  • [7] AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study
    Buchacz, Kate
    Baker, Rose K.
    Palella, Frank J., Jr.
    Chmiel, Joan S.
    Lichtenstein, Kenneth A.
    Novak, Richard M.
    Wood, Kathleen C.
    Brooks, John T.
    [J]. AIDS, 2010, 24 (10) : 1549 - 1559
  • [8] Pneumocystis jirovecii and cystic fibrosis
    Calderon, Enrique J.
    Friaza, Vicente
    Dapena, Francisco J.
    de La Horra, Carmen
    [J]. MEDICAL MYCOLOGY, 2010, 48 : S17 - S21
  • [9] Carmona Eva M, 2011, Ther Adv Respir Dis, V5, P41, DOI 10.1177/1753465810380102
  • [10] A NEW PROCEDURE FOR IDENTIFICATION OF PNEUMOCYSTIS CARINII CYSTS IN TISSUE SECTIONS AND SMEARS
    CHALVARDJIAN, AM
    GRAWE, LA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1963, 16 (04) : 383 - &